DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of ...

Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...

< Professor Markus Otto at the microscope: In a study, he and his colleagues showed that p-tau protein ... University Medicine Halle ...

"We are gratified to see these latest patent issuances," said Nader Yaghoubi, M.D., Ph.D., PathMaker’s Co-Founder and CEO. "We have been pioneering the application of neuromodulation to ALS, and these ...

MND Scotland says that around 450 people in the country are living with Motor Neurone Disease. One symptom that can easily be ...

A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...

Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.

There are 4 immunoassays for neurofilament light chain that demonstrate consistent performance in patients with ALS.

Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis. Neurology , 2025; 104 (6) DOI: 10.1212/WNL.0000000000213400 Cite This Page : ...

Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...

A new study published in the recent issue of Journal of American Medical Association found that the usage of verdiperstat, a ...